Pharmaceutical News

RSS

Alkermes' ALKS 5461 drug gets FDA Fast Track status for major depressive disorder

Alkermes plc today announced that the U.S. Food and Drug Administration has granted Fast Track status for ALKS 5461 for the adjunctive treatment of major depressive disorder in patients with an inadequate response to standard therapies.

10 Oct 2013

Heptares' StaR platform offers breakthrough solution to challenge associated with antibodies therapeutics

Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, achieved the first research milestone in its antibody therapeutics alliance with MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX), announced in February 2013.

10 Oct 2013

Physicians raise concerns about prescription drug abuse across Pennsylvania

Across Pennsylvania physicians have raised concerns about growing problems with prescription drug abuse.

10 Oct 2013

Adempas drug gets FDA approval for treatment of pulmonary hypertension

The U.S. Food and Drug Administration today approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Pulmonary hypertension is caused by abnormally high blood pressure in the arteries of the lungs.

10 Oct 2013

Researchers find no serious adverse effects of HPV vaccine in girls

Researchers at Karolinska Institutet in Sweden and their Danish colleagues have monitored HPV-vaccinated girls via patient data registries in order to examine the incidence of a wide range of diseases and thus determine if there are any serious adverse effects of the vaccine. Their results show no significant increase of the examined diseases in the vaccinated girls relative to their unvaccinated peers.

10 Oct 2013

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds boost a population of progenitor cells that can in turn repair MS-damaged nerve fibers.

10 Oct 2013

Anthem Blue Cross and Blue Shield offers tips for playing safe with prescription drugs

As we age, most of us come to depend on prescription drugs to help us live healthier, longer lives. But the very medications that we count on for better health could also land us in the hospital.

10 Oct 2013

WHO prequalifies affordable vaccine to protect children against Japanese encephalitis

An affordable vaccine to protect children against deadly Japanese encephalitis has been prequalified by the World Health Organization, paving the way to reach millions more children across Asia at risk for the disease.

10 Oct 2013

Paragon BioTeck, Horus Pharma sign distribution agreement for Ilast range of products

Paragon BioTeck, Inc. today announced that it has signed a distribution agreement with Horus Pharma for rights to supply the Ilast range of its medical-grade ocular hygiene and lid care products within the United States; it begins on an exclusive basis this month.

10 Oct 2013

CHD Bioscience's lead product can help mitigate increasing threat of HAIs

According to a recent report issued by the Centers for Disease Control, every year more than two million people develop infections that are resistant to antibiotics. Specific healthcare-associated infections are classified as urgent threats and affect approximately 1.7 million people annually across the United States, leading to death in nearly 99,000 patients.

9 Oct 2013

Risk of dying from invasive breast cancer lower among multivitamin/mineral users

Findings from a study involving thousands of postmenopausal women suggest that women who develop invasive breast cancer may benefit from taking supplements containing both multivitamins and minerals.

9 Oct 2013

U.S. Army Grants QR Pharma, UCLA $3M To Test TBI Treatment

...

9 Oct 2013

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).

9 Oct 2013

WHO approves new Japanese encephalitis vaccine to protect children in developing countries

A newly accessible vaccine against Japanese encephalitis (JE) is going to make the protection of more children in developing countries easier. The vaccine, manufactured in China, only needs to be given in one dose, it can be used for infants, and it is less expensive than other Japanese encephalitis vaccines.

9 Oct 2013

Proveca signs agreement with EMA to develop Glycopyrronium drug for children with sialorrhoea

NORTH West pharmaceutical company Proveca Limited has reached a key agreement with the European Medicines Agency that will enable the development of a new drug designed for children and young people.

9 Oct 2013

DSP to set up anti-cancer drugs sales company in US

Dainippon Sumitomo Pharma Co., Ltd. (DSP) announced on October 9 that it has decided to establish an anti-cancer drugs sales company in the United States as a wholly-owned subsidiary of DSP's 100% owned U.S. holding company.

9 Oct 2013

Widespread prescription of levothyroxine medication may cause more harm than good

A study of patients in the United Kingdom suggests widespread prescribing of the medication levothyroxine sodium to boost thyroid function among patients with borderline high levels of the thyroid-stimulating hormone thyrotropin (a sign of low thyroid function), raising the possibility of overtreatment, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

9 Oct 2013

New combinations of postoperative pain treatment decreased both pain and use of pain relievers

New combinations of postoperative pain treatment decreased both pain and the use of narcotic pain relievers according to two studies presented this week at the 2013 Clinical Congress of the American College of Surgeons.

9 Oct 2013

Gemcitabine drug improves survival rates in patients with pancreatic cancer

Among patients with pancreatic cancer who had surgery for removal of the cancer, treatment with the drug gemcitabine for 6 months resulted in increased overall survival as well as disease-free survival, compared with observation alone, according to a study in the October 9 issue of JAMA.

9 Oct 2013

Flumazenil reverses stress-triggered anxiety in methamphetamine dependant rats

SUNY Downstate Medical Center announced today that Sheryl Smith, PhD, professor of physiology and pharmacology, has published new findings demonstrating a reproducible pathology that may help shed light on anxiety and mood volatility in methamphetamine dependence.

9 Oct 2013

Pharmaceutical News

Alkermes' ALKS 5461 drug gets FDA Fast Track status for major depressive disorder

Heptares' StaR platform offers breakthrough solution to challenge associated with antibodies therapeutics

Physicians raise concerns about prescription drug abuse across Pennsylvania

Adempas drug gets FDA approval for treatment of pulmonary hypertension

Researchers find no serious adverse effects of HPV vaccine in girls

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Anthem Blue Cross and Blue Shield offers tips for playing safe with prescription drugs

WHO prequalifies affordable vaccine to protect children against Japanese encephalitis

Paragon BioTeck, Horus Pharma sign distribution agreement for Ilast range of products

CHD Bioscience's lead product can help mitigate increasing threat of HAIs

Risk of dying from invasive breast cancer lower among multivitamin/mineral users

U.S. Army Grants QR Pharma, UCLA $3M To Test TBI Treatment

ARIAD announces changes in Iclusig product labeling to reflect updated safety information

WHO approves new Japanese encephalitis vaccine to protect children in developing countries

Proveca signs agreement with EMA to develop Glycopyrronium drug for children with sialorrhoea

DSP to set up anti-cancer drugs sales company in US

Widespread prescription of levothyroxine medication may cause more harm than good

New combinations of postoperative pain treatment decreased both pain and use of pain relievers

Gemcitabine drug improves survival rates in patients with pancreatic cancer

Flumazenil reverses stress-triggered anxiety in methamphetamine dependant rats

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News